Efficacy of Amicar for Children Having Craniofacial Surgery (NCT02229968)
Efficacy of ฮต-Aminocaproic Acid (EACA) in Children Undergoing Craniofacial Reconstruction Surgery
๐ฉบ Plain-English Summary (8th-Grade Level)
The purpose of this study is to determine whether Amicar (ฮต-aminocaproic acid) is effective in reducing blood loss in children undergoing craniofacial reconstruction surgery. The investigators hypothesize that Amicar will decrease intraoperative blood loss and decrease the need for perioperative blood product administration in children undergoing craniofacial surgery.
Who can join: Review the eligibility criteria below.
Location: Vanderbilt University Medical Center โ Nashville, Tennessee
Age range: 2 Months to 36 Months
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- Vanderbilt University Medical Center โ Nashville, Tennessee
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Craniosynostosis
Explore by condition: All Craniosynostosis clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.